361 related articles for article (PubMed ID: 35816219)
21. E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities.
Zou Q; Liu M; Liu K; Zhang Y; North BJ; Wang B
Cell Oncol (Dordr); 2023 Jun; 46(3):545-570. PubMed ID: 36745329
[TBL] [Abstract][Full Text] [Related]
22. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
23. [Metabolic pathways controlled by E3 ligases: an opportunity for therapeutic targeting].
Taillandier D
Biol Aujourdhui; 2021; 215(1-2):45-57. PubMed ID: 34397374
[TBL] [Abstract][Full Text] [Related]
24. The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.
Shi X; Du Y; Li S; Wu H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408996
[TBL] [Abstract][Full Text] [Related]
25. E3 Ubiquitin Ligases: Key Regulators of Hormone Signaling in Plants.
Kelley DR
Mol Cell Proteomics; 2018 Jun; 17(6):1047-1054. PubMed ID: 29514858
[TBL] [Abstract][Full Text] [Related]
26. Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases.
Bulatov E; Valiullina A; Sayarova R; Rizvanov A
Immunol Lett; 2018 Oct; 202():44-51. PubMed ID: 30099009
[TBL] [Abstract][Full Text] [Related]
27. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
28. Functional roles of E3 ubiquitin ligases in gastric cancer.
Wang M; Dai W; Ke Z; Li Y
Oncol Lett; 2020 Oct; 20(4):22. PubMed ID: 32774495
[TBL] [Abstract][Full Text] [Related]
29. Targeting E3 ubiquitin ligases for cancer therapy.
Sun Y
Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
[TBL] [Abstract][Full Text] [Related]
30. Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity.
Aminu B; Fux J; Mallette E; Petersen N; Zhang W
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454069
[TBL] [Abstract][Full Text] [Related]
31. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
32. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
33. Role of E3 ubiquitin ligases in lung cancer.
Snoek BC; de Wilt LH; Jansen G; Peters GJ
World J Clin Oncol; 2013 Aug; 4(3):58-69. PubMed ID: 23936758
[TBL] [Abstract][Full Text] [Related]
34. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH.
Christian PA; Fiandalo MV; Schwarze SR
Mol Cancer; 2011 May; 10():57. PubMed ID: 21586138
[TBL] [Abstract][Full Text] [Related]
35. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
36. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
Qi J; Tripathi M; Mishra R; Sahgal N; Fazli L; Ettinger S; Placzek WJ; Claps G; Chung LW; Bowtell D; Gleave M; Bhowmick N; Ronai ZA
Cancer Cell; 2013 Mar; 23(3):332-46. PubMed ID: 23518348
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.
Yuan Y; Chen X; Huang E
Technol Cancer Res Treat; 2019; 18():1533033819886867. PubMed ID: 31694481
[TBL] [Abstract][Full Text] [Related]
38. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
Zhou W; Wei W; Sun Y
Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
[TBL] [Abstract][Full Text] [Related]
39. Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.
Wang H; Lu Y; Wang M; Wu Y; Wang X; Li Y
J Mol Med (Berl); 2021 Feb; 99(2):193-212. PubMed ID: 33392633
[TBL] [Abstract][Full Text] [Related]
40. E3 ubiquitin ligase: A potential regulator in fibrosis and systemic sclerosis.
Huang XL; Zhang L; Duan Y; Wang YJ; Zhao JH; Wang J
Cell Immunol; 2016; 306-307():1-8. PubMed ID: 27406900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
